# Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV

> **NCT03201367** · NA · COMPLETED · sponsor: **Zagazig University** · enrollment: 40 (actual)

## Conditions studied

- Portal Vein Thrombosis

## Interventions

- **DRUG:** Rivaroxaban
- **OTHER:** symptomatic therapy for ascites, abdominal pain

## Key facts

- **NCT ID:** NCT03201367
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-01
- **Primary completion:** 2016-08-01
- **Final completion:** 2016-08-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03201367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03201367, "Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03201367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*